Hyunghoon Cho is an Assistant Professor at Yale School of Medicine in the Department of Biomedical Informatics & Data Science, with a secondary appointment in the Department of Computer Science. He received his PhD in Electrical Engineering and Computer Science from MIT (2019) and MS/BS in Computer Science from Stanford University (2013). His research focuses on computational challenges in biomedical data privacy, single-cell genomics, and network biology. Assistant Professor (Primary): Biomedical Informatics & Data Science Assistant Professor (Secondary): Computer Science Appointments: Yale School of Medicine | Broad Institute (Schmidt Fellow) Research Themes: Privacy-Enhancing Technologies for genomic and health data Scalable AI/ML tools for omics data analysis Structured biological modeling for system-level discovery His work includes secure GWAS, transcriptomic privacy assessment, and sfkit - a federated genomic analysis toolkit. He received the NIH Director's Early Independence Award and leads NSF-funded projects on confidential genome analytics. Awards: NIH Director's Early Independence Award Lab Members: Haris Smajlović (Postdoc), Vincent Angelo (CBB MS), Denis Loginov (Senior Software Engineer), Lucy Zheng (CBB PhD)
Dr. Birgit Frauscher is the Lincoln Financial Group Distinguished Professor in Neurobiology at Duke University School of Medicine, where she serves as Professor of Neurology and holds a secondary appointment in the Department of Biomedical Engineering at the Duke Pratt School of Engineering. She is currently the Director of the Duke Comprehensive Epilepsy Center and leads the Analytical Neurophysiology (ANPHY) Lab. Her clinical and research work focuses on epilepsy and sleep medicine, utilizing both invasive and non-invasive electrical recordings to study brain activity in humans. Dr. Frauscher completed her medical training, neurology residency, and subspecialty training in electroencephalography, epilepsy, and sleep medicine at the Medical University of Innsbruck in Austria. After completing her clinical training in 2008, she earned her habilitation degree in 2011. She further specialized in intracranial EEG and signal analysis during a visiting professorship at the Montreal Neurological Institute and Hospital, McGill University (2013-2015), where she later served as an Attending Epileptologist and Group Leader of Epilepsy. Her research interests focus on developing novel seizure-independent EEG markers for the epileptogenic zone, investigating sleep-epilepsy interactions, and using intracranial EEG to study brain physiology during wakefulness and sleep. Her work aims to improve epilepsy diagnosis, prognosis, and treatment outcomes by better localizing the epileptic focus. Dr. Frauscher's recent publications demonstrate her continued leadership in epilepsy research, with over 170 peer-reviewed papers and an H-index of 62. Dr. Frauscher has received several prestigious awards including the Clinician-Scientist awards of the FRSQ (2018-2023), the Michael Prize of the International League against Epilepsy (2019), and the Ernst Niedermeyer Prize from the Austrian Epilepsy Society (2015). Her scholarly work has significantly advanced clinical knowledge in epilepsy and sleep medicine, establishing her as a leading figure in the field. As Director of the Duke Comprehensive Epilepsy Center and head of the ANPHY lab, Dr. Frauscher oversees a research program dedicated to advancing neuroscience through innovative approaches to studying brain activity. Her lab employs quantifiable tools to investigate neurophysiological and pathological processes related to epilepsy and sleep, with the ultimate goal of improving patient outcomes through better understanding of brain function.
Anirban Paul is an Associate Professor in the Department of Neuroscience and Experimental Therapeutics at Pennsylvania State University, affiliated with the Penn State Neuroscience Institute. His research focuses on cellular and molecular mechanisms of GABAergic inhibitory circuits, with particular emphasis on interneuron biology and its implications in neurological disorders. Dr. Paul's research spans multiple neuroscience domains, with primary focus on GABAergic inhibitory circuits and interneuron biology. His work investigates how specific neuron subtypes, particularly Chandelier cells and cortical interneurons, contribute to brain function and dysfunction. He has made significant contributions to understanding the role of these cells in schizophrenia, Alzheimer's disease, and other neurological conditions. His research integrates molecular, cellular, and systems-level approaches to uncover fundamental mechanisms of neural circuit assembly, plasticity, and function. Key areas include RNA regulation in neuronal development, transcriptomic subtypes of inhibitory neurons, and cell-type specific vulnerabilities in neurodegenerative diseases. His research portfolio demonstrates consistent productivity with publications spanning from 2003 to 2025, showing an evolving focus from basic molecular neuroscience to translational research in neurological disorders. Recent work emphasizes single-cell analysis techniques and the role of specific interneuron populations in disease mechanisms, particularly in schizophrenia and Alzheimer's disease. His publications appear in high-impact neuroscience journals including Neuron, BMC Biology, and Frontiers in Cellular Neuroscience. Dr. Paul has received the NARSAD Young Investigator Award (2018), recognizing his promising research in neuroscience. His scientific contributions have been supported by multiple competitive grants from prestigious organizations including the National Institute on Aging (NIA) and the Brain and Behavior Research Foundation. He serves as Principal Investigator on multiple active research projects, including two major grants from the National Institute on Aging focused on cell-type specific risk and resilience in Alzheimer's disease and aging (2021-2024 and 2024-2026), as well as previous projects from the Brain and Behavior Research Foundation investigating Chandelier cells in schizophrenia. His research program demonstrates sustained funding and scientific leadership in the field of interneuron biology and its clinical implications.
Thomas Perlmann is a Professor in Molecular Developmental Biology at the Karolinska Institutet , leading research at the Department of Cell and Molecular Biology and serving as Director of the Stockholm Branch of the Ludwig Institute for Cancer Research. He also holds the position of Secretary General of the Nobel Assembly and Nobel Committee for Physiology or Medicine since 2016. Ph.D. , Karolinska Institutet, 1991 M.Sc. , Stockholm University, 1987 Research Interests : The Perlmann lab investigates the specification and maintenance of dopamine neurons in the central nervous system, with a focus on transcriptional regulation , signaling pathways , and regenerative medicine applications for Parkinson’s disease and other neurodegenerative disorders. His work bridges developmental biology and neuroscience , emphasizing the role of transcription factors in neuronal identity and function. Recent Research Trends : Perlmann’s recent publications highlight the use of single-cell RNA sequencing to dissect dopamine neuron heterogeneity , epigenetic regulation during development, and transcriptomic changes in Parkinson’s disease models. His studies increasingly leverage multiomics and bioinformatics to map neuronal lineage trajectories and gene expression dynamics. Scientific Awards : Royal Medal by HM the King (2025) Nicholson Lecturer, Rockefeller University (2011) Göran Gustafsson Prize in Molecular Biology (1999) Eric K. Fernström Young Investigator Prize (1997) Advising & Collaborations : While no student names are explicitly listed, Perlmann collaborates extensively with researchers such as Malin Parmar , Agnete Kirkeby , and Per Svenningsson on projects related to neuronal development and cell therapy . His lab receives funding from institutions like the Ludwig Institute for Cancer Research . Labs & Teams : The Perlmann Lab at Karolinska Institutet includes researchers like Linda Gillberg , Laura Lahti , and Behzad Yaghmaeian Salmani , who work on mouse models , single-cell transcriptomics , and bioinformatics to study dopamine neuron biology.
Ranjan Singh is a Professor at the Division of Physics, Nanyang Technological University (NTU) Singapore, specializing in terahertz photonics and metamaterials. He holds an elected fellowship from OPTICA (OSA) for pioneering work in ultrafast terahertz photonics, active metamaterials, and sensors. His research focuses on hybrid THz-electronic-photonic technologies for 6G communications, topological photonics, spintronics, quantum materials, and high-Tc superconductors. Education: B.Eng. in Telecommunications (Bangalore University, 2001); M.Tech in Photonics (Cochin University, 2004); Ph.D. in Photonics (Oklahoma State University, 2009). Postdoctoral research at Los Alamos National Laboratory (2009–2013). Research emphasizes on-chip THz topological photonics for next-gen communication systems, with notable achievements including a $7M grant for TERACOMM (on-chip THz topological photonics). His work integrates AI-driven beamforming, reconfigurable metasurfaces, and phase-change materials for adaptive THz systems. Key awards include the 2020 Web of Science 'Top 1% Highly Cited Researcher' distinction. His lab, TeraX Labs (founded 2013), develops cutting-edge technologies like THz brain-computer interfaces, quantum emitters, and spintronic sensors. Over $12M in competitive grants has fueled innovations in THz integrated circuits, tunable optical coatings, and ultra-sensitive biosensors. Advancing 6G/XG wireless, Singh's team designs topological beamformers, intelligent reflecting surfaces (IRS), and terahertz metamaterials for multi-link systems. His work bridges theoretical physics and applied engineering, with a focus on energy-efficient, reconfigurable photonic systems.
Beatriz Noheda is a Full Professor of Functional Nanomaterials at the University of Groningen's Faculty of Science and Engineering, where she chairs the Solid State Materials for Electronics group at the Zernike Institute for Advanced Materials. She also serves as the founding Director of the Groningen Cognitive Systems and Materials center (CogniGron). Her academic journey began with a PhD in Physics from the Autonomous University of Madrid in 1996, followed by research positions at Brookhaven National Laboratory and various European institutions before joining Groningen through the prestigious Rosalind Franklin Fellowship program in 2004. Her research interests span the physics of functional materials with particular emphasis on ferroelectric, piezoelectric, and multiferroic thin films . She investigates the relationship between structure and functionality, focusing on nano-domain control through strain engineering and the unique properties of domain walls. Her work bridges fundamental physics with two promising application areas: piezoelectric energy harvesting for low-power electronics and the development of novel materials for neuromorphic computing . This dual focus reflects her vision of enabling the next technological revolution through materials science. Noheda's publication record shows a clear evolution from fundamental structural studies of ferroelectric materials toward cutting-edge research in hafnia-based ferroelectrics and neuromorphic computing materials. Her most recent work focuses on oxygen migration in hafnium-zirconium oxide systems, metal-insulator transitions in nickelates, and the development of novel ferroelectric phases suitable for next-generation electronic devices. These publications demonstrate her leadership in advancing the field from basic understanding toward practical applications in memory devices and cognitive computing systems. Fellow of the American Physical Society (2011) - awarded for fundamental structural studies of new phases in perovskite-type ferroelectric materials and domain nanostructures IEEE Robert E. Newnham Ferroelectrics Award (2020) - for outstanding contributions to understanding giant piezoelectricity in lead zirconate titanate Member of the Netherlands Academy of Technology and Innovation (AcTI) (2022) Elected Senior member IEEE (2021) Rosalind Franklin Fellowship (2004) - enabling her successful academic career in Groningen Noheda has secured substantial research funding throughout her career, including a Rosalind Franklin Fellowship (2004-2009), VIDI-NWO Fellowship (2004-2008), TOP-NWO project on Functional Nanowalls (2007-2012), multiple Zernike Institute Dieptestrategie grants, and a significant TOP-PUNT grant (2016-2021). She has supervised numerous students and early-career researchers, contributing to the development of the next generation of materials scientists. Her leadership extends to editorial roles on prestigious journals including Science, Physical Review Applied, and npj Quantum Materials. As Director of CogniGron, Noheda leads an interdisciplinary center focused on developing materials and systems for cognitive computing. Her team combines expertise in functional oxides, nanoelectronics, and neuromorphic engineering to create novel computing paradigms inspired by the human brain. The center represents a strategic initiative at the University of Groningen to position itself at the forefront of cognitive systems research.
Paul O'Toole is a Professor of Microbial Genomics and Principal Investigator at the APC Microbiome Ireland, University College Cork. His research focuses on the gut microbiome's role in health, aging, and disease, particularly in the context of diet and probiotics. He leads projects like the ELDERMET study on elderly nutrition and the NU-AGE project exploring Mediterranean diets' anti-aging effects. He holds a BA (Mod.) from Trinity College Dublin and a PhD from Lund University, with postdoctoral training in Canada and New Zealand. Key grants include studies on dairy-derived microbiota, probiotic strain improvement, and microbiome analysis in aging populations. He has published extensively on Lactobacillus genomics, gut-brain interactions, and microbiome-driven health outcomes. His work bridges fundamental microbiology with clinical applications, emphasizing translational research. Scientific highlights include discovering microbiome links to cognitive decline, demonstrating dietary modulation of gut microbes to combat obesity, and identifying keystone species in healthy aging. He advocates for sustainability in conservation and food systems, reflecting his interdisciplinary approach to global health challenges.
Marc V Fuccillo is an Associate Professor of Neuroscience at the Perelman School of Medicine, University of Pennsylvania, where he leads a research laboratory focused on understanding the neural circuit mechanisms underlying behavioral control. His work bridges molecular, synaptic, and behavioral approaches to investigate how striatal circuits regulate mouse behavior from simple motor patterns to complex goal-directed actions. Fuccillo holds dual appointments in the Neuroscience and Cell and Molecular Biology Graduate Groups at Penn and maintains an active laboratory investigating the synaptic and circuit basis of neuropsychiatric disorders. Education: B.A. in Molecular and Cellular Biology and Music Performance (Violin) from Brown University (1998) Ph.D. in Developmental Genetics from New York University School of Medicine (2007) M.D. from New York University School of Medicine (2008) Fuccillo's research centers on the synaptic and circuit mechanisms of behavioral control, with particular emphasis on striatal circuits. His laboratory employs a range of technologies including mouse genetics, in vitro electrophysiology, in vivo imaging, and quantitative behavioral analysis to explore how neural circuits of the striatum regulate behavior and how disruptions in these circuits contribute to neuropsychiatric disorders. His work has particularly focused on autism-associated abnormalities in behavioral control, examining how synaptic adhesion molecules like neuroligins and neurexins shape circuit function and behavior, with significant findings regarding D1 dopamine receptor positive medium spiny neurons in the nucleus accumbens. Analysis of Fuccillo's recent publications reveals a strong focus on striatal circuit function across multiple dimensions. His work spans molecular neuroscience (examining synaptic adhesion molecules), cellular physiology (studying specific neuron types in striatal circuits), systems neuroscience (mapping circuit connectivity), and behavioral neuroscience (quantifying motor learning and decision-making). A unifying theme is how disruptions in specific molecular pathways lead to circuit-level abnormalities that manifest as behavioral phenotypes relevant to neuropsychiatric disorders, with particular attention to autism, OCD, and schizophrenia models. Scientific Recognition: Publications in high-impact journals including Nature Neuroscience, Current Biology, Cell Reports, and Neuron Research supported by multiple NIH grants including NIMH F32, NIMH K01, and HHMI Gilliam Fellowship awards for lab members Fuccillo actively mentors a diverse group of trainees including postdoctoral fellows, graduate students, and undergraduates. His laboratory has produced numerous successful alumni who have gone on to faculty positions, medical residencies, and graduate programs at prestigious institutions. His mentoring approach emphasizes technical skill development across multiple neuroscience disciplines while fostering independent scientific thinking. Current research in his lab is supported by NIH funding focused on understanding the molecular architecture of striatal circuits and their role in behavioral control, with three major research directions exploring molecular logic of striatal circuits, circuit mechanisms of behavioral control, and striatal dysfunction in neuropsychiatric disease models. The Fuccillo Laboratory operates within the Department of Neuroscience at the University of Pennsylvania, with access to state-of-the-art facilities for molecular, electrophysiological, imaging, and behavioral neuroscience research. The lab maintains active collaborations with other neuroscience research groups at Penn and beyond, creating a rich intellectual environment for studying the neural basis of behavior. Current research directions include investigating whether there is a molecular logic to striatal circuit composition, how striatal circuits shape behavioral control, and what mouse models of autism, schizophrenia, and OCD can reveal about striatal circuit dysfunction in disease pathophysiology.
Kathryn Roeder is the UPMC University Professor of Statistics and Life Sciences at Carnegie Mellon University (CMU), affiliated with the Dietrich College of Humanities and Social Sciences and the Departments of Statistics & Data Science and Computational Biology. Her research focuses on developing statistical methods for genetic and genomic data, particularly in identifying autism risk genes and analyzing single-cell multi-omic data. She earned her Ph.D. in Statistics from Penn State University and has been at CMU since 1994, previously serving as Vice Provost for Faculty (2015–2019). Education: Ph.D. in Statistics, Penn State University (1988) B.S. in Wildlife Resources, University of Idaho (1982) Research Interests: Her work integrates modern statistical techniques (high-dimensional statistics, machine learning, networks) to study complex diseases like autism and schizophrenia. Recent efforts include tools for analyzing single-cell RNA-seq and proteomic data, such as UNICORN, DAWN, and SCEPTRE. Key Awards: COPSS Distinguished Achievement Award (2020) National Academy of Sciences Member (2019) COPSS Presidents’ Award (1997) AAAS Fellow (2020) Advising & Grants: She has advised over 20 Ph.D. students, many contributing to landmark studies in autism genetics. Her grants include NIH funding for projects like the Autism Sequencing Consortium. Current research teams focus on computational biology and statistical genetics. Labs & Collaborations: Her lab develops software tools (e.g., TADA, MIND) and collaborates with the Autism Sequencing Consortium and iPSYCH-BROAD Consortium on large-scale genomic studies.
Susanne Weis is a Research Professor and Group Leader of the 'Variability of the Brain' group at the Department of Brain and Behavior (INM-7), part of the Institute of Neuroscience and Medicine (INM) at Research Center Jülich GmbH. Her work focuses on understanding brain variability through advanced neuroimaging techniques and machine learning, with particular emphasis on sex differences, hormonal influences, and clinical applications in mental health. Her research interests include neuroimaging methodologies, machine learning applications in cognitive neuroscience, and the structural-functional relationships underlying brain variability. She investigates how factors like sex hormones and naturalistic stimuli (e.g., movies) affect brain connectivity and cognitive performance, aiming to improve diagnostic and predictive tools for disorders such as schizophrenia and Alzheimer’s disease. Publications highlight her contributions to developing datasets (e.g., SpEx), analyzing confound leakage in ML models, and exploring meta-analytic networks during naturalistic viewing. Her work bridges basic science and clinical impact, addressing challenges in interpreting neuroimaging data and advancing personalized medicine approaches. In her role as a group leader, Weis oversees research projects and collaborates with interdisciplinary teams. She is affiliated with the Helmholtz Association and contributes to the broader scientific community through her research in neuroimaging and computational neuroscience.
Jeff Moher is an Associate Professor of Psychology and Co-Chair of the Department of Psychology at Connecticut College, where he has been teaching since 2017. He also serves as the Data, Information, and Society Pathway Co-Coordinator, demonstrating his leadership within the institution. His educational background includes a Ph.D. and M.A. from Johns Hopkins University and a B.S. from the University of Michigan. This strong academic foundation has prepared him for his research and teaching career in cognitive psychology. Moher's research focuses on cognitive psychology and cognitive neuroscience, particularly visual attention and cognition in action. His work investigates why distractions occur, when they are likely to arise, and what mechanisms humans can harness to avoid them. He has found that humans employ various cognitive mechanisms to minimize distractions based on explicit knowledge, task goals, object properties, and recent experience, though he has also discovered surprising limitations in attentional selection. His research is particularly relevant given that over 3,000 people are killed annually in the United States from distracted driving. His recent publications show a consistent trajectory examining attentional mechanisms, distraction, and visual processing across different contexts. His work frequently employs sophisticated methodologies to measure both cognitive and motor responses to distractions, revealing how seemingly minor distractions can accumulate to induce serious performance costs. Moher's research is currently funded by grants from the National Science Foundation and the National Institutes of Health, indicating the significance and quality of his work. He likely mentors numerous students through the department's research groups, contributing to their development as researchers. He directs the CAMELab (Center for Attention, Movement, and Embodied Learning), which utilizes multiple methodologies including eye-tracking, electroencephalography, three-dimensional reach-tracking, and psychophysics to approach questions about attention and distraction. Current projects in his lab explore why salient distractors cause people to give up quickly during visual search, the brain mechanisms involved in learning to ignore distractions, how internal distractions impact physical interactions with the world, and how hand movement paths reveal information about attentional processes.
John D. Murray is the Gregg L. Engles Associate Professor of Psychological and Brain Sciences at Dartmouth College and an Adjunct Associate Professor of Psychiatry at Yale School of Medicine. He holds a PhD in Physics from Yale University (2013) and a BS in Physics and Mathematics from Yale (2006). His research focuses on computational neuroscience and computational psychiatry, with secondary appointments in Physics and Neuroscience at Yale until 2023. His work integrates computational modeling, neuroimaging, and systems neuroscience to study decision-making processes, cortical organization, and psychiatric disorders. Collaborators include prominent researchers like Dr. John Krystal and Dr. Anticevic. Research interests include hierarchical brain organization, neuroimaging analysis techniques, and pharmacological effects on neural circuits. His lab (Murray Lab) develops computational tools like PsychRNN for cognitive task modeling. Notable contributions include linking transcriptomic data to neuroimaging patterns and modeling LSD’s effects on brain topography. He has been featured in YaleNews and Nature Communications for innovations in mapping mental illness variability and neural circuit dynamics. Grants and collaborations span translational neuroscience, addiction, and PTSD research through partnerships with Yale’s Center for Biomedical Data Science and VA National Center for PTSD. His interdisciplinary approach bridges physics, computer science, and clinical psychiatry to advance understanding of brain function and dysfunction.
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Martha Ann Bell is a University Distinguished Professor of Psychology and College of Science Faculty Fellow at Virginia Tech. She leads the Cognition, Affect, and Psychophysiology (CAP) Lab, focusing on developmental cognitive neuroscience and the integration of emotion and cognition in early development. Her work examines EEG/ECG biomarkers, executive function, temperament, and maternal-child interactions. Dr. Bell holds a PhD in Human Development from the University of Maryland (1992), an MS in Child and Family Studies from the University of Tennessee (1983), and a BS in Home Economics from Carson-Newman College (1978). She has held progressive roles from Assistant Professor (1996) to her current distinguished title. Her research interests include developmental changes in brain-behavior relations, neurophysiological correlates of emotion regulation, and longitudinal predictors of child development. Recent work explores maternal emotion coaching, EEG neuromarkers of ADHD, and the neurodevelopmental impacts of nutrition. Key awards include the Virginia Tech University Distinguished Professorship (2021) and College of Science Faculty Fellowship (2019–2025). Her publications span developmental psychobiology, neuroimaging methods, and temperament-behavior links. Dr. Bell’s advising and grants focus on interdisciplinary developmental science. The CAP Lab collaborates on projects involving infant neuroimaging, maternal-child physiology, and early childhood interventions.
Carina Mallard is Professor of Experimental Perinatal Brain Injury Research and Pro-Vice-Chancellor at the University of Gothenburg since July 2023, where she oversees research infrastructure and chairs the Research Board. She previously served as Deputy Vice-Chancellor (2021–2023) and Head of Core Facilities (2018–2021). Her academic career began with a Physiology degree from Lund University and a PhD in Pediatrics at the University of Auckland (1995), followed by a professorship appointment in 2006. Her research focuses on perinatal brain injury , particularly in premature infants , investigating neuroinflammatory mechanisms maternal dietary interventions neurovascular unit dynamics microglia activation long-term consequences of maternal obesity . Recent publications highlight her work on neonatal rodent models , transcriptomic profiling , and anti-inflammatory therapies . Key themes include RNA degradation , mitochondrial protection , and immune-neurovascular interactions . She has supervised 20 doctoral students since 2004 and collaborates internationally with institutions like King's College London. Contact details include two institutional emails and physical addresses across Gothenburg's biomedical campuses. Her leadership roles span research strategy, doctoral education, and EU-level scientific initiatives.
